Zymeworks Inc (ZYME)
8.55
-0.01
(-0.12%)
USD |
NASDAQ |
Apr 24, 16:00
8.00
-0.55
(-6.43%)
After-Hours: 04:50
Zymeworks Revenue (TTM): 76.01M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 76.01M |
| September 30, 2023 | 461.58M |
| June 30, 2023 | 447.70M |
| March 31, 2023 | 446.14M |
| December 31, 2022 | 412.48M |
| September 30, 2022 | 29.86M |
| June 30, 2022 | 31.62M |
| March 31, 2022 | 27.95M |
| December 31, 2021 | 26.68M |
| September 30, 2021 | 22.49M |
| June 30, 2021 | 20.74M |
| March 31, 2021 | 31.33M |
| December 31, 2020 | 38.95M |
| September 30, 2020 | 25.15M |
| June 30, 2020 | 30.36M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.89M |
| December 31, 2019 | 29.54M |
| September 30, 2019 | 56.59M |
| June 30, 2019 | 50.79M |
| March 31, 2019 | 64.90M |
| December 31, 2018 | 53.02M |
| September 30, 2018 | 74.16M |
| June 30, 2018 | 72.23M |
| March 31, 2018 | 51.57M |
| December 31, 2017 | 51.76M |
| September 30, 2017 | 3.923M |
| June 30, 2017 | 5.976M |
| March 31, 2017 | 10.98M |
| December 31, 2016 | 11.01M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
20.74M
Minimum
Jun 2021
461.58M
Maximum
Sep 2023
120.62M
Average
31.33M
Median
Mar 2021
Revenue (TTM) Benchmarks
| Emergent BioSolutions Inc | 1.024B |
| MariMed Inc | 148.60M |
| Viemed Healthcare Inc | 183.01M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |